New York Codes, Rules and Regulations › Title 10 - DEPARTMENT OF HEALTH › Chapter V - Medical Facilities › Subchapter C - State Hospital Code › Article 1 - General Provisions › Part 709 - Determination Of Public Need For Medical Facility Construction › Section 709.8 - Bone marrow transplantation (bmt) services

Current through Register Vol. 46, No. 28, July 10, 2024
(a) This methodology will be utilized to
					 evaluate certificate of need applications involving the initiation of
					 allogeneic bone marrow transplantation services. It is the intent of the State
					 Hospital Review and Planning Council that this methodology, when used in
					 conjunction with the planning standards and criteria set forth in section
					 709.1 of this Part, become a
					 statement of planning principles and decisionmaking tools for directing the
					 distribution of bone marrow transplantation services. The goals and objectives
					 of the methodology expressed herein are expected to insure that an adequate
					 number of BMT services are available to provide access to care and avoid the
					 unnecessary duplication of resources.
(b) The factors and methodology for
					 determining the public need for allogeneic BMT services shall include, but not
					 be limited to, the following:
(1) The need
					 for BMT services shall be planned on a statewide basis.
(2) Based on the current status of BMT
					 technology, the number of people expected to be candidates for BMT therapy is
					 13.2 per million population per year. This will be reviewed on an annual basis
					 to determine if any adjustment is indicated.
(3) The capacity of each BMT bed is six
					 patients/year.
(4) A BMT service
					 shall have a minimum of four beds.
(5) Priority consideration will be given to
					 applicants that propose to provide this service within the facility's current
					 capacity.
(6) Where public need is
					 established herein, priority consideration will be given to applicants that
					 agree to serve the medically indigent and patients regardless of the source of
					 payment.
(7) In addition, each
					 applicant applying to initiate a BMT service must meet the following standards:
(i) Each applicant must demonstrate the
					 availability of a bone marrow transplant team under the direction of a
					 full-time medical director with training in immunology or hematology who had
					 advanced training and experience in bone marrow transplantation.
(ii) The bone marrow transplant team shall
					 include specialists in the following areas: chemotherapy, radiation therapy,
					 social work, nursing, infectious disease control, immunology, oncology,
					 hematology, and expertise in intensive cardiopulmonary medicine.
(iii) The transplant program shall be
					 supported by a blood bank with a capacity to support four to six patients/day.
					 This requires the availability of a blood separator, a central blood
					 repository, and an irradiator for blood products.
(iv) The bone marrow transplantation program
					 shall provide or make arrangements for the harvesting of bone marrow.
(v) The services of an immunogeneticist and a
					 cytogeneticist shall be available to the transplant program.
(vi) The transplant program shall have
					 available clinical laboratories possessing permits issued under article 5,
					 title 5 of the Public Health Law, in the categories of: virology, diagnostic
					 immunology, bacteriology, mycology, mycobacteriology, parasitology,
					 cytogenetics, cellular immunology and histocompatibility.
(vii) There shall be an organized follow-up
					 program for transplant patients following discharge, including data management
					 resources to maintain records on the long-term survival of transplant
					 patients.
(viii) Each facility
					 providing BMT services shall agree to provide annual reports to the Department
					 of Health on utilization levels and patient origin data.